Fertility warning
This medicine may affect fertility.
Leaflet DOXORUBICINA ACCORD 2mg / ml concentrate for solution for infusion
- Product code:
- W65789004
- Quantity:
- 1
- Indicated for:
- cancer
- Route of administration:
- infusion
- Substance:
- doxorubicin (antineoplastic agent)
- ATC
- L01DB01 — Antineoplastic and immunomodulating agents | Cytotoxic antibiotics and related substances | Anthracyclines and related substances
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Doxorubicin is a chemotherapy drug used for the treatment of various types of cancer, including breast cancer, leukemia, and lymphoma. It belongs to the anthracycline class and works by inhibiting DNA synthesis in cancer cells, preventing their division and growth.
The medication is administered intravenously, usually as part of a specific regimen, under the supervision of an oncologist. It is effective in reducing tumor size and slowing disease progression.
Side effects may include nausea, vomiting, hair loss, bone marrow suppression, and, in rare cases, cardiac toxicity. Close monitoring is essential during treatment.
Consult your doctor to discuss the benefits and risks of treatment with Doxorubicin. This medication must be administered exclusively in controlled environments, such as hospitals.
The medication is administered intravenously, usually as part of a specific regimen, under the supervision of an oncologist. It is effective in reducing tumor size and slowing disease progression.
Side effects may include nausea, vomiting, hair loss, bone marrow suppression, and, in rare cases, cardiac toxicity. Close monitoring is essential during treatment.
Consult your doctor to discuss the benefits and risks of treatment with Doxorubicin. This medication must be administered exclusively in controlled environments, such as hospitals.
General data about DOXORUBICINA ACCORD 2mg / ml
- Substance:
- doxorubicin
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W65789004
- Concentration:
- 2mg / ml
- Pharmaceutical form:
- concentrate for solution for infusion
- Quantity:
- 1
- Product type:
- Generic medicine
- Price:
- 42.76 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for doxorubicin
- concentrate for dispersion for infusion
- concentrate for solution for infusion
- lyophilisate for solution for injection
- lyophilisate and solvent for solution for injection
- powder for concentrate for solution for infusion
- powder for solution for infusion
- powder and mixture for concentrate for liposomal dispersion for infusion
Concentrations available for doxorubicin
- 10mg
- 2mg/ml
- 50mg